Metabolic alterations in paediatric GH deficiency

详细信息    查看全文

• 作者：Juliane Rothermel ; MD ; Prof Dr Thomas Reinehr ; MD ; PhD<sup> ; sup><sup>T.Reinehr@kinderklinik-datteln.desup>
• 关键词：growth hormone ; lipids ; glucose metabolism ; adipokines ; fat mass intima ; media thickness
• 刊名：Best Practice & Research Clinical Endocrinology & Metabolism
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：30
• 期：6
• 页码：757-770
• 全文大小：703 K
• 卷排序：30

文摘

Growth hormone (GH) has a large number of metabolic effects, involving lipid and glucose homoeostasis, lean and fat mass. Growth hormone deficiency (GHD) is associated with a metabolic profile similar to the Metabolic Syndrome which is characterized by dyslipidemia, insulin resistance, haemostatic alterations, oxidative stress, and chronic inflammation. GH replacement treatment in GHD children improves these cardiovascular risk factors, while cessation of GH is associated with a deterioration of most of these risk factors. However, it is unclear whether the changes of these risk factors are associated with an increased risk of cardiovascular diseases especially after discontinuing GH treatment. GH treatment itself can lead to insulin resistance, which probably also influences the cardiovascular health status. Therefore, longitudinal studies with the primary outcome cardiovascular diseases are needed in GHD children. Furthermore, new approaches such as metabolomic studies might be helpful to understand the relationship between GHD, GH treatment, and cardiovascular diseases.